JO
CHTP

John Overdeck’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

John Overdeck’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-176,866
Closed -$784K – 2525
2013
Q4 		$784K Buy
+176,866
New +$598K ﹤0.01% 1448
2013
Q3 		– Sell
-27,595
Closed -$64K – 2347
2013
Q2 		$64K Buy
+27,595
New +$55.8K ﹤0.01% 1915

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GH
Green Holdings Hamilton, Bermuda $9.16M AUM 15.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

John Overdeck's CHTP Position: Q1 2014 in Review

John Overdeck sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q1 2014, closing a stake of 176,866 shares — an estimated $784K sold.

John Overdeck first reported a position in CHTP in Q2 2013 and held it in 2 quarters. The position peaked at $784K in Q4 2013. 85 funds tracked by Wall St. Rank hold CHTP as of Q1 2014.

  • John Overdeck reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q1 2014 after selling out during the quarter.
  • John Overdeck sold 176,866 CHELSEA THERAPEUTICS INT'L LTD shares in Q1 2014, an estimated $784K.
  • John Overdeck first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 2 quarters.
  • John Overdeck's CHELSEA THERAPEUTICS INT'L LTD position peaked at $784K in Q4 2013.
  • 85 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q1 2014.

Based on Two Sigma Investments's 13F filing for Q1 2014, filed 15 May 2014.